Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.

Van Rompay KKA, Olstad KJ, Sammak RL, Dutra J, Watanabe JK, Usachenko JL, Immareddy R, Roh JW, Verma A, Shaan Lakshmanappa Y, Schmidt BA, Di Germanio C, Rizvi N, Liu H, Ma ZM, Stone M, Simmons G, Dumont LJ, Allen AM, Lockwood S, Pollard RE, Ramiro de Assis R, Yee JL, Nham PB, Ardeshir A, Deere JD, Jain A, Felgner PL, Coffey LL, Iyer SS, Hartigan-O'Connor DJ, Busch MP, Reader JR

Open source

DOI
10.1371/journal.ppat.1009925
Published
2022 Apr
Container
PLoS pathogens
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.ppat.1009925,
  title = {Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.},
  author = {Van Rompay KKA and Olstad KJ and Sammak RL and Dutra J and Watanabe JK and Usachenko JL and Immareddy R and Roh JW and Verma A and Shaan Lakshmanappa Y and Schmidt BA and Di Germanio C and Rizvi N and Liu H and Ma ZM and Stone M and Simmons G and Dumont LJ and Allen AM and Lockwood S and Pollard RE and Ramiro de Assis R and Yee JL and Nham PB and Ardeshir A and Deere JD and Jain A and Felgner PL and Coffey LL and Iyer SS and Hartigan-O'Connor DJ and Busch MP and Reader JR},
  year = {2022},
  journal = {PLoS pathogens},
  doi = {10.1371/journal.ppat.1009925},
  url = {https://doi.org/10.1371/journal.ppat.1009925}
}

RIS

TY  - JOUR
TI  - Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.
AU  - Van Rompay KKA
AU  - Olstad KJ
AU  - Sammak RL
AU  - Dutra J
AU  - Watanabe JK
AU  - Usachenko JL
AU  - Immareddy R
AU  - Roh JW
AU  - Verma A
AU  - Shaan Lakshmanappa Y
AU  - Schmidt BA
AU  - Di Germanio C
AU  - Rizvi N
AU  - Liu H
AU  - Ma ZM
AU  - Stone M
AU  - Simmons G
AU  - Dumont LJ
AU  - Allen AM
AU  - Lockwood S
AU  - Pollard RE
AU  - Ramiro de Assis R
AU  - Yee JL
AU  - Nham PB
AU  - Ardeshir A
AU  - Deere JD
AU  - Jain A
AU  - Felgner PL
AU  - Coffey LL
AU  - Iyer SS
AU  - Hartigan-O'Connor DJ
AU  - Busch MP
AU  - Reader JR
PY  - 2022
JO  - PLoS pathogens
DO  - 10.1371/journal.ppat.1009925
UR  - https://doi.org/10.1371/journal.ppat.1009925
ER  - 

APA

KKA, V. R., KJ, O., RL, S., J, D., JK, W., JL, U., R, I., JW, R., A, V., Y, S. L., BA, S., C, D. G., N, R., H, L., ZM, M., M, S., G, S., LJ, D., AM, A., S, L., RE, P., R, R. D. A., JL, Y., PB, N., A, A., JD, D., A, J., PL, F., LL, C., SS, I., DJ, H., MP, B., & JR, R. (2022). Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation.. PLoS pathogens. https://doi.org/10.1371/journal.ppat.1009925

Source records